1. Health Insurance Review and Assessment Service. Statistical indicators for medical expenses. Available from: http://www.hira.or.kr/dummy.do?pgmid=HIRAA020045030000&cmsurl=/cms/information/05/03/03/stats_surface.html. [Accessed October 10, 2013].
2. Organization for Economic Cooperation and Development. Health at a glance 2011: OECD indicators. Available from: http://www.oecd.org/els/health-systems/49105858.pdf. [Accessed November 22, 2013].
3. Organization for Economic Cooperation and Development. Pharmaceutical expenditure. In: Health at a Glance: Europe 2012. Paris, France: OECD Publishing, 2012. Available from: 10.1787/9789264183896-55-en. [Accessed November 22, 2013].
4. Dabigatran—a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs;Godman;Front Pharmacol,2014
5. Pharmaceutical policies in European countries in response to the global financial crisis;Vogler;South Med Rev,2011